295 related articles for article (PubMed ID: 27999289)
21. A high number of IgG4-positive plasma cells rules out nodular lymphocyte predominant Hodgkin lymphoma.
Kiil K; Bein J; Schuhmacher B; Thurner L; Schneider M; Hansmann ML; Hartmann S
Virchows Arch; 2018 Dec; 473(6):759-764. PubMed ID: 30259184
[TBL] [Abstract][Full Text] [Related]
22. Deficiency of suppressor-inducer (CD4+CD45RA+) T cells in autism.
Warren RP; Yonk LJ; Burger RA; Cole P; Odell JD; Warren WL; White E; Singh VK
Immunol Invest; 1990 Jun; 19(3):245-51. PubMed ID: 2142123
[TBL] [Abstract][Full Text] [Related]
23. Differing reflections of paediatric classical Hodgkin's lymphoma on local and distant immunological microenvironments: a flow cytometric study.
Savaşan S; AlQanber B; Henry M; Buck S; Gadgeel M
J Clin Pathol; 2020 Mar; 73(3):176-179. PubMed ID: 31542728
[TBL] [Abstract][Full Text] [Related]
24. Detection of T-regulatory cells has a potential role in the diagnosis of classical Hodgkin lymphoma.
Bosler DS; Douglas-Nikitin VK; Harris VN; Smith MD
Cytometry B Clin Cytom; 2008 Jul; 74(4):227-35. PubMed ID: 18271019
[TBL] [Abstract][Full Text] [Related]
25. Occurrence of nodular lymphocyte-predominant hodgkin lymphoma in hermansky-pudlak type 2 syndrome is associated to natural killer and natural killer T cell defects.
Lorenzi L; Tabellini G; Vermi W; Moratto D; Porta F; Notarangelo LD; Patrizi O; Sozzani S; de Saint Basile G; Latour S; Pace D; Lonardi S; Facchetti F; Badolato R; Parolini S
PLoS One; 2013; 8(11):e80131. PubMed ID: 24302998
[TBL] [Abstract][Full Text] [Related]
26. Spatial phenotyping of nodular lymphocyte predominant Hodgkin lymphoma and T-cell/histiocyte-rich large B-cell lymphoma.
Younes S; Subramanian A; Khan A; Zhao S; Binkley M; Natkunam Y
Blood Cancer J; 2024 May; 14(1):92. PubMed ID: 38821935
[TBL] [Abstract][Full Text] [Related]
27. Tumour cell characteristics and microenvironment composition correspond to clinical presentation in newly diagnosed nodular lymphocyte-predominant Hodgkin lymphoma.
Hartmann S; Soltani AS; Bankov K; Bein J; Hansmann ML; Rosenwald A; Bernd HW; Feller A; Ott G; Möller P; Stein H; Klapper W; Borchmann P; Engert A; Eichenauer DA
Br J Haematol; 2022 Nov; 199(3):382-391. PubMed ID: 35880396
[TBL] [Abstract][Full Text] [Related]
28. [Relationship between lymphocyte immunophenotypes and histologic subtypes of Hodgkin's lymphoma and its significance].
Zhang Y; Li XZ; Wen ZH; Chen XY; Zhang G; Wang X; Wu ZQ; Zhao T
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Aug; 17(4):888-93. PubMed ID: 19698223
[TBL] [Abstract][Full Text] [Related]
29. Peripheral T-cell lymphomas of follicular helper T-cell type frequently display an aberrant CD3(-/dim)CD4(+) population by flow cytometry: an important clue to the diagnosis of a Hodgkin lymphoma mimic.
Alikhan M; Song JY; Sohani AR; Moroch J; Plonquet A; Duffield AS; Borowitz MJ; Jiang L; Bueso-Ramos C; Inamdar K; Menon MP; Gurbuxani S; Chan E; Smith SM; Nicolae A; Jaffe ES; Gaulard P; Venkataraman G
Mod Pathol; 2016 Oct; 29(10):1173-82. PubMed ID: 27312067
[TBL] [Abstract][Full Text] [Related]
30. Cyclin D1 expression and polysomy in lymphocyte-predominant cells of nodular lymphocyte-predominant Hodgkin lymphoma.
Cho BB; Kelting SM; Gru AA; LeGallo RD; Pramoonjago P; Goldin TA; Heitz CT; Aguilera NS
Ann Diagn Pathol; 2017 Feb; 26():10-15. PubMed ID: 28038705
[TBL] [Abstract][Full Text] [Related]
31. CD57+ T-cells are a subpopulation of T-follicular helper cells in nodular lymphocyte predominant Hodgkin lymphoma.
Sattarzadeh A; Diepstra A; Rutgers B; van den Berg A; Visser L
Exp Hematol Oncol; 2015; 4():27. PubMed ID: 26380151
[TBL] [Abstract][Full Text] [Related]
32. PD-1, a follicular T-cell marker useful for recognizing nodular lymphocyte-predominant Hodgkin lymphoma.
Nam-Cha SH; Roncador G; Sanchez-Verde L; Montes-Moreno S; Acevedo A; Domínguez-Franjo P; Piris MA
Am J Surg Pathol; 2008 Aug; 32(8):1252-7. PubMed ID: 18594468
[TBL] [Abstract][Full Text] [Related]
33. Foxp3(high) and Foxp3(low) Treg cells differentially correlate with T helper 1 and natural killer cells in peripheral blood.
Lee SK; Kim JY; Jang BW; Hur SE; Na BJ; Lee M; Fukui A; Gilman-Sachs A; Kwak-Kim J
Hum Immunol; 2011 Aug; 72(8):621-6. PubMed ID: 21600259
[TBL] [Abstract][Full Text] [Related]
34. [Nodular lymphocyte-predominant Hodgkin's lymphoma and differential diagnoses].
Hartmann S; Cogliatti S; Hansmann ML
Pathologe; 2013 May; 34(3):233-43. PubMed ID: 23494280
[TBL] [Abstract][Full Text] [Related]
35. Cytokine gene expression profile distinguishes CD4+/CD57+ T cells of the nodular lymphocyte predominance type of Hodgkin's lymphoma from their tonsillar counterparts.
Atayar C; Poppema S; Visser L; van den Berg A
J Pathol; 2006 Feb; 208(3):423-30. PubMed ID: 16353293
[TBL] [Abstract][Full Text] [Related]
36. Analysis of peripheral blood T-cell subsets and regulatory T-cells in multiple myeloma patients.
Huang LQ; Wang JX; He K; Jiang YZ; Wei ZL; Huang DP; Chu LL
Cell Mol Biol (Noisy-le-grand); 2018 Apr; 64(5):113-117. PubMed ID: 29729703
[TBL] [Abstract][Full Text] [Related]
37. Reference ranges of lymphocyte subsets in healthy adults and adolescents with special mention of T cell maturation subsets in adults of South Florida.
Valiathan R; Deeb K; Diamante M; Ashman M; Sachdeva N; Asthana D
Immunobiology; 2014 Jul; 219(7):487-96. PubMed ID: 24661720
[TBL] [Abstract][Full Text] [Related]
38. Low expression of CD39(+) /CD45RA(+) on regulatory T cells (Treg ) cells in type 1 diabetic children in contrast to high expression of CD101(+) /CD129(+) on Treg cells in children with coeliac disease.
Åkesson K; Tompa A; Rydén A; Faresjö M
Clin Exp Immunol; 2015 Apr; 180(1):70-82. PubMed ID: 25421756
[TBL] [Abstract][Full Text] [Related]
39. Significant differences of lymphocytes isolated from ascites of patients with ovarian cancer compared to blood and tumor lymphocytes. Association of CD3+CD56+ cells with platinum resistance.
Bamias A; Tsiatas ML; Kafantari E; Liakou C; Rodolakis A; Voulgaris Z; Vlahos G; Papageorgiou T; Tsitsilonis O; Bamia C; Papatheodoridis G; Politi E; Archimandritis A; Antsaklis A; Dimopoulos MA
Gynecol Oncol; 2007 Jul; 106(1):75-81. PubMed ID: 17433425
[TBL] [Abstract][Full Text] [Related]
40. Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy.
Wu SP; Liao RQ; Tu HY; Wang WJ; Dong ZY; Huang SM; Guo WB; Gou LY; Sun HW; Zhang Q; Xie Z; Yan LX; Su J; Yang JJ; Zhong WZ; Zhang XC; Wu YL
J Thorac Oncol; 2018 Apr; 13(4):521-532. PubMed ID: 29269008
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
